Clinical Trials in Astana, Kazakhstan

8 recruiting

Showing 18 of 8 trials

Recruiting
Phase 2

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Inflammatory Bowel DiseasesCrohn's Disease
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)385 enrolled159 locationsNCT06226883
Recruiting
Phase 4

Effectiveness of Weight Loss Methods on Lifespan for Metabolic Syndrome

Metabolic Syndrome
University Medical Center, Kazakhstan220 enrolled1 locationNCT06410352
Recruiting
Phase 2

PD-1 Inhibitors Maintenance for cHL Post-autoHCT

Hodgkin Lymphoma
St. Petersburg State Pavlov Medical University83 enrolled3 locationsNCT06812858
Recruiting
Not Applicable

Preventive Use of PIPAC in Locally Advanced Gastric Cancer.

Gastric Cancer
National Research Oncology and Transplantology Center, Kazakhstan160 enrolled1 locationNCT06784765
Recruiting
Phase 2

Study to Assess Safety and Efficacy of Treating Symptomatic, Ischemic, Chronic Congestive Heart Failure Patients with an LVEF of ≤40% with Fresh, Uncultured, Autologous, Adipose-derived Regenerative Cells Isolated from Lipoaspirate.

Heart FailureMyocardial InjuryCoronary Artery Disease+1 more
Ralf Rothoerl36 enrolled1 locationNCT06705023
Recruiting
Not Applicable

The Gut Microbiome in Chronic Heart Failure

Heart Failure
Nazarbayev University90 enrolled1 locationNCT06573892
Recruiting

Clinical Efficacy of Ustekinumab in Crohn's Disease

Crohn's Disease
Kazakhstan Scientific Society for Study of intestine diseases150 enrolled4 locationsNCT06523647
Recruiting

Evaluation of the Effectiveness and Safety of Vibro-acoustic Pulmonary Therapy (VAPT) in Complex Therapy for Acute Respiratory Failure of Mixed Type I-II Stages in Comparison With Percussion Massage in Cardiac Surgical Patients in the Early Postoperative Period

Cardiac Surgical Patients (CABG,Mammary Coronary Bypass Surgery,Plastic and Replacement of Valves, Atrial Septal Defect,Ventricular Septal Defect)
Bark Technology LLP310 enrolled5 locationsNCT06320483